A randomised double blind trial versus placebo does not confirm the benefit of alpha-interferon in polyneuropathy associated with monoclonal IgM
- PMID: 10960293
- PMCID: PMC1737051
- DOI: 10.1136/jnnp.69.2.279
A randomised double blind trial versus placebo does not confirm the benefit of alpha-interferon in polyneuropathy associated with monoclonal IgM
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical